Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bicycle Therapeutics Q3 EPS $(0.96) Down From $(0.59) YoY

Bicycle Therapeutics Q3 EPS $(0.96) Down From $(0.59) YoY

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.96) per share. This is a 62.71 percent decrease over losses of $(0.59) per share from the same period last year.

byBenzinga Newsdesk

November 3, 2022

1 minute read

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.96) per share. This is a 62.71 percent decrease over losses of $(0.59) per share from the same period last year.

UBS Maintains Buy on Informatica, Lowers Price Target to $28

By Benzinga Newsdesk

July 28, 9:49 AM

UBS analyst Karl Keirstead maintains Informatica (NYSE:INFA) with a Buy and lowers the price target from $31 to $28.

INFA

News

What’s Going On With QuantumScape (QS) Stock?

By Henry Khederian

August 1, 3:45 PM

QuantumScape Corp (NYSE: QS) shares are trading lower by 6.31% to $12.48 going into the close of Tuesday's session. The stock may be pulling back following recent strength.